Kane William P Jr 4
4 · BioXcel Therapeutics, Inc. · Filed Jun 17, 2020
Insider Transaction Report
Form 4
Kane William P Jr
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-06-15+110,000→ 110,000 totalExercise: $52.82Exp: 2030-06-14→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of June 15, 2020 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.